CXCR3 and neoplasm: At the same time, we found fewer tumour-specific CD8+ T-cells in the lungs, and lower expression of the activation marker CD43 and GzmB in CD8+ T-cells in the tumour when CXCR3 was blocked compared to untreated IAV infected tumour bearing mice (Fig 7D and 7E).